Spectral properties of light affect plasma and pituitary gonadotropins in male rats

In order to find out whether different light spectra have any role in regulating the gonadotropin levels in male rats, we compared the 24-hour patterns of plasma and pituitary gonadotropins in rats kept for 7 days in natural or in cool white artificial lighting (exp. I). The intensity and periodicity of the two lighting conditions were adjusted as similar as possible. Further, we measured plasma and pituitary gonadotropins in the middle of the light period and in the middle of the dark period in rats kept for 7 days under artificial lightings of three different spectra (exp. II). In both experiments, in all lighting conditions we found higher plasma levels of LH and FSH during the dark than the light period. The differences were statistically significant only when the illumination contained more long and/or short wavelengths than the usual cool white laboratory lighting. The pituitary contents of gonadotropins were not found to vary with the periodicity of lighting. In the 24-hour patterns the overall plasma levels were higher and the pituitary contents of gonadotropins lower in natural lighting than in cool white lighting. It was concluded that the spectral properties of light influence the secretion of gonadotropins in male rats, but the mechanism involved remains to be clarified.     

Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.

OBJECTIVES--To examine the relation between coronary heart disease and the apolipoprotein E phenotypes in patients with non-insulin dependent diabetes mellitus. DESIGN--Cross sectional study. SETTING--District around Kuopio University Central Hospital, East Finland. SUBJECTS--138 men with non-insulin dependent diabetes and 64 men without diabetes as controls. MAIN OUTCOME MEASURE--Apolipoprotein E phenotype, electrocardiographic abnormalities, other signs of coronary heart disease. RESULTS--The prevalences of definite myocardial infarction and ischaemic electrocardiographic changes were highest in the diabetic men with the phenotypes E4/4 or E4/3 (25% (95% confidence interval 18% to 32%) and 50% (42% to 58%) respectively), although the difference between the phenotype groups was not significant. The prevalence of angina pectoris was 69% (61% to 77%) in men with the phenotypes E4/4 or E4/3 (p = 0.005 compared with other phenotypes), 41% (33% to 49%) in men with phenotype E3/3, and 47% (39% to 55%) in those with phenotypes E2/2 or E2/3. Similarly, the simultaneous presence of angina pectoris and ischaemic electrocardiographic changes was highest in the diabetic men with the phenotypes E4/4 or E4/3 (42% v 22% in those with E3/3 and 29% in those with E2/2, E2/3; p = 0.038). Overall, the prevalence of any evidence of coronary heart disease among the diabetic subjects with the phenotypes E4/4 or E4/3 was 81% (p = 0.011 compared with other phenotypes), 58% in those with phenotype E3/3, and 53% in those with phenotypes E2/2 or E3/3. CONCLUSION--Apolipoprotein E phenotypes E4/4 and E4/3 modulate the risk of coronary heart disease in men with non-insulin dependent diabetes.